Benjamin C. Brown

Benjamin C. Brown

Auto-generated profile, based on publicly available information

Benjamin C. Brown

Department of Endocrinology, Xiangya Hospital, Central South University, Changsha, Hunan, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2020 in The Plant Cell
Verified
Journal Article
Open access
PDF file
NKNaoki Kitaoka
Naoki Kitaoka
Juan ZhangJuan Zhang
Juan Zhang
RORichard K Oyagbenro
Richard K Oyagbenro
BBBenjamin Brown
Benjamin Brown
YWYisheng Wu
Yisheng Wu
RPReuben Peters
Reuben Peters
Plants can contain biosynthetic gene clusters (BGCs) that nominally resemble those found in microbes. However, while horizontal gene transmission is often observed in microbes, plants are limited to vertical gene transmission, implying that their BGCs may exhibit distinct inheritance patterns. Rice (Oryza sativa) contains two unlinked BGCs involved in diterpenoid phytoalexin metabolism, with one clearly required for momilactone biosynthesis, while the other is associated with production of phytocassanes. Here, in the process of elucidating momilactone biosynthesis, genetic evidence was found demonstrating a role for a cytochrome P450 (CYP) from the other “phytocassane” BGC. This CYP76M8 acts after the CYP99A2/3 from the “momilactone” BGC, producing a hemiacetal intermediate that is oxidized to the eponymous lactone by a short-chain alcohol dehydrogenase also from this BGC. Thus, the “momilactone” BGC is not only incomplete, but also fractured by the need for CYP76M8 to act in between steps catalyzed by enzymes from this BGC. Moreover, as supported by similar activity observed with orthologs from the momilactone-producing wild-rice species Oryza punctata, the presence of CYP76M8 in the other “phytocassane” BGC indicates interdependent evolution of these two BGCs, highlighting the distinct nature of BGC assembly in plants.

7 August 2023 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
CCChanghan Chen
Changhan Chen
TXTingTing Xie
TingTing Xie
YZYujin Zhang
Yujin Zhang
YWYiyan Wang
Yiyan Wang
FYFang Yu
Fang Yu
YXYang Xia
Yang Xia
Significance Statement: Hypoxia drives kidney damage and progression of CKD. Although erythrocytes respond rapidly to hypoxia, their role and the specific molecules sensing and responding to hypoxia in CKD remain unclear. In this study, we demonstrated in a mouse model that erythrocyte ENT1-AMPD3 is a master energy regulator of the intracellular purinergic hypoxic compensatory response that promotes rapid energy supply from extracellular adenosine, eAMPK-dependent metabolic reprogramming, and O2 delivery, which combat renal hypoxia and progression of CKD. ENT1-AMPD3-AMPK-BPGM comprise a group of circulating erythroid-specific biomarkers, providing early diagnostic and novel therapeutic targets for CKD. Background: Hypoxia drives kidney damage and progression of CKD. Although erythrocytes respond rapidly to hypoxia, their role and the specific molecules sensing and responding to hypoxia in CKD remain unclear. Methods: Mice with an erythrocyte-specific deficiency in equilibrative nucleoside transporter 1 (eEnt1 −/− ) and a global deficiency in AMP deaminase 3 (Ampd3 −/− ) were generated to define their function in two independent CKD models, including angiotensin II (Ang II) infusion and unilateral ureteral obstruction (UUO). Unbiased metabolomics, isotopic adenosine flux, and various biochemical and cell culture analyses coupled with genetic studies were performed. Translational studies in patients with CKD and cultured human erythrocytes examined the role of ENT1 and AMPD3 in erythrocyte function and metabolism. Results: eEnt1 −/− mice display severe renal hypoxia, kidney damage, and fibrosis in both CKD models. The loss of eENT1-mediated adenosine uptake reduces intracellular AMP and thus abolishes the activation of AMPKα and bisphosphoglycerate mutase (BPGM). This results in reduced 2,3-bisphosphoglycerate and glutathione, leading to overwhelming oxidative stress in eEnt1 −/− mice. Excess reactive oxygen species (ROS) activates AMPD3, resulting in metabolic reprogramming and reduced O2 delivery, leading to severe renal hypoxia in eEnt1 −/− mice. By contrast, genetic ablation of AMPD3 preserves the erythrocyte adenine nucleotide pool, inducing AMPK-BPGM activation, O2 delivery, and antioxidative stress capacity, which protect against Ang II-induced renal hypoxia, damage, and CKD progression. Translational studies recapitulated the findings in mice. Conclusion: eENT1-AMPD3, two highly enriched erythrocyte purinergic components that sense hypoxia, promote eAMPK-BPGM–dependent metabolic reprogramming, O2 delivery, energy supply, and antioxidative stress capacity, which mitigates renal hypoxia and CKD progression.

21 May 2020 in JCI Insight
Verified
Journal Article
Closed access
SSSeisuke Sayama
Seisuke Sayama
ASAnren Song
Anren Song
BBBenjamin C. Brown
Benjamin C. Brown
JCJacob Couturier
Jacob Couturier
XCXiaoli Cai
Xiaoli Cai
YXYang Xia
Yang Xia
Insufficient O 2 supply is frequently associated with fetal growth restriction (FGR), a leading cause of perinatal mortality and morbidity. Although the erythrocyte is the most abundant and only cell type to deliver O 2 in our body, its function and regulatory mechanism in FGR remain unknown. Here, we report that genetic ablation of mouse erythrocyte equilibrative nucleoside transporter 1 (eENT1) in dams, but not placentas or fetuses, results in FGR. Unbiased high-throughput metabolic profiling coupled with in vitro and in vivo flux analyses with isotopically labeled tracers led us to discover that maternal eENT1–dependent adenosine uptake is critical in activating AMPK by controlling the AMP/ATP ratio and its downstream target, bisphosphoglycerate mutase (BPGM); in turn, BPGM mediates 2,3-BPG production, which enhances O 2 delivery to maintain placental oxygenation. Mechanistically and functionally, we revealed that genetic ablation of maternal eENT1 increases placental HIF-1α; preferentially reduces placental large neutral aa transporter 1 (LAT1) expression, activity, and aa supply; and induces FGR. Translationally, we revealed that elevated HIF-1α directly reduces LAT1 gene expression in cultured human trophoblasts. We demonstrate the importance and molecular insight of maternal eENT1 in fetal growth and open up potentially new diagnostic and therapeutic possibilities for FGR.

18 April 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
DCDaniel H. Craighead
Daniel H. Craighead
BZBrian P. Ziemba
Brian P. Ziemba
KFKaitlin Freeberg
Kaitlin Freeberg
MRMatthew J Rossman
Matthew J Rossman
BBBenjamin C. Brown
Benjamin C. Brown
DSDouglas R. Seals
Douglas R. Seals
Background: Vascular endothelial dysfunction associated with decreased nitric oxide (NO)‐bioavailability secondary to excessive superoxide‐associated oxidative stress is a key antecedent of age‐associated cardiovascular diseases. High‐resistance inspiratory muscle strength training (IMST) is a promising form of time‐efficient physical training for promoting cardiovascular health with aging. However, the efficacy and mechanisms of IMST for improving endothelial function in older adults have not been established. We hypothesized IMST may induce changes in the molecular composition of the circulating blood that improve endothelial function via superoxide suppression‐related increases in NO bioavailability. Purpose: To determine the efficacy of IMST for improving vascular endothelial function in vivo , the influence of IMST‐induced changes in circulating factors on endothelial superoxide and NO production ex vivo , and IMST‐induced changes in the molecular composition of the circulation. Methods: Twenty older adults underwent 6 weeks of IMST (30 breaths/day; 6 days/week; 75% maximum inspiratory pressure [PI MAX ]) (n=10, 5M/5F, age: 68±2 years) or low‐resistance sham (15% PI MAX ) training (n=10, 6M/4F, age 70±2 years) in a randomized, double‐blind study. Vascular endothelial function was assessed via brachial artery flow‐mediated dilation [FMDBA]. HUVECs were cultured with serum collected at baseline and post‐intervention (n=12; 5 IMST, 7 sham). NO production stimulated with acetylcholine and basal superoxide production from HUVECs were measured using fluorescent microscopy. Plasma metabolite levels were assessed via targeted metabolomics (n=14; 7 IMST, 7 sham) at baseline and post‐intervention with ultra‐high‐performance liquid chromatography‐mass spectrometry. Results: FMDBA increased 45% after 6 weeks of IMST (pre: 4.7±0.8 Δ%, post: 6.8±0.7 Δ%; p=0.01) but not after sham training (pre: 3.7±0.6 Δ%, post: 3.8±0.6 Δ%; p=0.99), such that FMDBA was 79% higher in the IMST group compared to sham training post‐intervention (p=0.01). HUVEC production of NO was 66% higher (p=0.04) while superoxide production was 38% lower post‐intervention in the IMST group vs. sham, though the latter was not statistically significant (p=0.17). Plasma metabolomics revealed greater levels of arginine (p=0.02) and ornithine (p=0.06) in the IMST group vs. sham post‐intervention, consistent with increased NO production. A greater level of dehydroascorbate (p=0.04) and changes in markers of glutathione synthesis (decreased alanine p=0.02; increased cystine p=0.06) were observed in the IMST group vs. sham post‐intervention, suggesting greater antioxidant defense status with IMST. Conclusion: These findings suggest IMST is a promising intervention for improving vascular endothelial function in older adults, in part by inducing changes in the molecular composition of the blood that increases NO bioavailability by suppressing superoxide. Support or Funding Information: AHA 18POST33990034, R21 AG061677